VACCINES DO NOT CURE NOR

PREVENT YOU FROM ACQUIRING THE

VIRUS. IT ONLY HELPS DEVELOP
IMMUNITY AGAINST THE VIRUS.

FOR DUMMIES
COVID-19
VACCINES

01 Pfizer-BioNTech
WHO CAN People 12
GET THIS? years and older
HOW 2 shots
#1
BAL
IN GLO
TYPE mNRA MANY Given 3 weeks
SALES

PRICE
93 0millionphdospes SHOTS (21 days) apart
per 100

AUTHORIZED About 95%. Apparently 10 0% at

December 11, 2020 preventing hospitalization and death.

02 Moderna Pregn
ant wo
men m

WHO CAN People

receiv ay

18
e the v
the be accine
nefit o if

GET THIS? years and older

vaccin f
ating a
woma pregn
ant

2 shots
n outw

HOW
poten e ighs th
tial va e
ccine

MANY Given
risks.

4 weeks -WHO
SHOTS (28 days) apart
TYPE mNRA About 95%. Apparently 10 0% at
preventing hospitalization and death.
1200- 1800
PRICE
php per dose #2
IN
mNRA type
AUTHORIZED GLOBAL contain
materia
December 18, 2020 SALES the viru
s that ca
l from
uses
COVID
-19

Sources: gov.ph Department of Health Philippines

World Health Organization, CDC Center for Disease Control and Prevention
(Terry M., 2021) BioSpace, UPDATED Comparing COVID-19 Vaccines: Timelines, Types and Prices.
 03 Johnson & Johnson’s
Janssen
Viral Vector WHO CAN People 18
TYPE
GET THIS? years and older
50in0thephUS p HOW 1 shot
PRICE
MANY Fully vaccinated
AUTHORIZED
SHOTS after 2 weeks
November 15 Phase III
VIRAL VECTO
contai
R TYPE
n a mo
dified
ptomatic COVID-
versio
66%-72% at preventinlyg sym
n of a
differe

19 infections Apparent th.100% at preventing

virus a nt
nd in i
mater ts shell i
hospitalization and dea ial fro s
m the
that ca virus
uses C
OVID
-19

04 Sinovac Biotech
Inactivated
WHO CAN People 18 TYPE
SARS-CoV-2 virus
GET THIS? years and older
HOW 2 shots $60 per dose
in China
PRICE
MANY
SHOTS AUTHORIZED
CHINA BASED
50.38% to 91.25%, depending on the
clinical trial

05 Oxford/AstraZeneca
WHO CAN People with
Viral Vector GET THIS? comorbidities COMORBIDITES
TYPE
HOW 2 shots increas

MANY
ed risk
of sever
Given 8-12
COVID e
-19, inc
luding

SHOTS weeks apart.

obesity
, cardio

105php
vascula
disease r
, respira
PRICE disease
tory
in the US and dia
betes.

AUTHORIZED
January 12, 2021 in Europe tic COVID-19
70% at preventing symtiopton ma
infections, hospitaliza and death.

"COVID-19 vaccines that are granted with

Emergency Use Authorization (EUA) by the
Food and Drug Administration (FDA) are
considered safe and effective based on
the available evidence to date."
-DOH,
PHILIPPINES
Sources: gov.ph Department of Health Philippines
World Health Organization, CDC Center for Disease Control and Prevention
(Terry M., 2021) BioSpace, UPDATED Comparing COVID-19 Vaccines: Timelines, Types and Prices.
 06 Novavax
WHO CAN People 18
TYPE Protein-based
GET THIS? years and older
76in5thephUS p HOW 2 shots
PRICE
MANY
AUTHORIZED
SHOTS PROTEIN BAS
TYPE ED
November 15 Phase III include
harmle
ss
pieces (p
roteins)
virus th of the
at cause
s
COVID
-19 inst
ead of
the entir

89.3% in its Phase III trial in the UK

e germ.

07 Gamaleya Sputnik V
Viral Vector
WHO CAN People 18 TYPE
(non-replicating)
GET THIS? years and older
HOW 2 shots
MANY Given 3 weeks PRICE unknown
SHOTS apart
AUTHORIZED
matic COVID- March 19,2021
91% at preventing sympto
19 infections, 100% against moderate to
severe cases

08 Bharat Biotech
WHO CAN People 18
Inactivated Virus GET THIS? years and older VINIRAUCSTIVATED
TYPE
HOW 2 shots Conta

MANY
ins in
Given 4 weeks SARS activa
-CoV ted

SHOTS apart. using -2 vir

us

10 0php
Who
Inact le-Vir
ion
PRICE ivated
Vero
in the US platfo
rm te Cell
chno
logy.

AUTHORIZED
April 19, 2021
ection; 78% against
100% against severe infre;
mild, moderate and seve 70% against
asymptomatic

R
A L L OTHEERE ARE
LIKECINES, TH
VAC S OF O NS BU
T
R I S K A T I
LIC E-
COMEPRE OR LIF
SEV EATENINGRE
THR CTIONS A ARE.
REA REMELY R
EXT

tenderness of injection site

fatigue, headache, nausea, body pain,
fever, vomiting, muscle pain, chills,
allergic reactions.

Sources: gov.ph Department of Health Philippines

World Health Organization, CDC Center for Disease Control and Prevention
(Terry M., 2021) BioSpace, UPDATED Comparing COVID-19 Vaccines: Timelines, Types and Prices.